Skip to main content
. 2020 Aug 18;17(8):840–849. doi: 10.30773/pi.2020.0102

Table 2.

Comorbidities in both groups of 125 participants

Variable NSA (N=83) SA (N=42) Total (N=125) χ2 or t p-value
Comorbidity (axis I) 1.030 0.310
 No 4 (4.8) 4 (9.5) 8 (6.4)
 Yes 79 (95.2) 38 (90.5) 117 (93.6)
Comorbidities (axis-I) 16.900 0.089
 Anxiety disorders 9 (10.7) 0 (0.0) 9 (7.1)
 Bipolar and related disorders 6 (7.2) 1 (2.4) 7 (5.6)
 Depressive disorders 34 (41.0) 23 (54.8) 57 (45.6)
 Disruptive, impulse-control and conduct disorders 2 (2.4) 0 (0.0) 2 (1.6)
 Dissociative disorders 0 (0.0) 1 (2.4) 1 (0.8)
 Gender dysphoria 1 (1.2) 0 (0.0) 1 (0.8)
 Attention deficit/hyperactivity disorders 2 (2.4) 0 (0.0) 2 (2.4)
 Tic disorders 1 (1.2) 0 (0.0) 1 (1.2)
 Obsessive-compulsive and related disorders 4 (4.8) 0 (0.0) 4 (3.2)
 Somatic symptom and related disorders 2 (2.4) 4 (9.5) 6 (4.8)
 Substance related disorders 6 (7.1) 4 (9.5) 10 (7.9)
 Trauma and stressor related disorders 12 (14.5) 4 (9.5) 16 (12.8)

Values are presented as number (%). NSA: non-suicide attempters, SA: suicide attempters